Top Markets
Coin of the day
Mural Oncology plc Mural Oncology plc

Mural Oncology plc

MURA
Rang in aandelen #27070
Mural Oncology Plc, a clinical-stage company, is dedicated to discovering and... Mural Oncology Plc, a clinical-stage company, is dedicated to discovering and advancing immune-based therapies for individuals battling cancer. Its primary drug candidate, nemvaleukin alfa, is currently under investigation as a standalone agent for mucosal melanoma and in partnership with pembrolizumab for platinum-resistant ovarian cancer. Additionally, the company is progressing projects centered on modified interleukin-18 and tumor-specific interleukin-12. Incorporated in 2017, Mural Oncology maintains its headquarters in Dublin, Ireland. By November 15, 2023, the company had transitioned from being a subsidiary of Alkermes plc.
Aandeelprijs
$2.04
Laatst gesynchroniseerd: 2025-12-09
Marktkapitalisatie
$35.38M
Verandering (1 dag)
0.00%
Verandering (1 jaar)
-2.39%
Land
IE
Handel Mural Oncology plc (MURA)

Categorie

Koersgeschiedenis voor Mural Oncology plc (MURA)
Hoogste slotkoers: $2.04 op 2025-12-01

Laagste slotkoers: $3.85 op 2023-11-01
Koersgeschiedenis van Mural Oncology plc van 2023 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) 1.79%
2025 -42.95%
2024 -13.07%
2023 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$120.74 -14.98%
AU
$760.05 6.79%
CH